The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Coronary Artery Disease Global Market Report 2024, the coronary artery disease market is expected to show promising growth in the forecast period.

Introduction: A Lucrative Market on the Rise

• Rapid expansion from $26.3 billion in 2023 to $28.97 billion in 2024.
• Compound Annual Growth Rate (CAGR) of 10.2%.

A Glance into Historic Growth Drivers

• Prevalence of coronary artery disease.
• Growth in minimally invasive surgeries.
• Increase in sedentary lifestyles.
• Aging population and CAD prevalence.
• Evolution of pharmacological treatments.

Projected Surge: Factors Fueling Future Growth

• Forecasted expansion to $42.65 billion in 2028.
• Lifestyle factors play a pivotal role.
• Focus shifts to telemedicine and remote monitoring.
• Interventional cardiology procedures witness an upsurge.
• Embrace of value-based healthcare models.
• Development of novel drug therapies.

Emerging Trends in the Forecast Period

• Gene therapies enter the fray.
• Integration of AI in diagnosis.
• Heightened focus on mental health in CAD care.
• Rise of home-based healthcare services.
• Adoption of remote cardiac rehabilitation.

View More On The Coronary Artery Disease Market Report 2024 – https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Influence of Rising CAD Prevalence on Market Dynamics

• Surge in CAD cases attributed to lifestyle changes.
• Treatment options include drugs and procedures.
• Statistics highlight the severity of the issue.
• Key players in the CAD market landscape.

Spearheading Innovation: AI-Infused Blood Tests

• Major companies integrate AI in diagnostic tests.
• PrecisionCHD: A breakthrough in early CAD detection.
• Features and efficacy of AI-based blood tests.

Abbott Laboratories’ Strategic Acquisition

• Acquisition of Cardiovascular Systems Inc. for $890 million.
• Enhancing treatment solutions for vascular diseases.
• Cardiovascular Systems Inc.: A leader in innovative medical devices.

Segmentation Insights: Understanding Market Dynamics

1. Treatment: Medication, Surgery, Additional Therapy, Other Treatments.
2. Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis.
3. Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels.
4. End-User: Hospitals, Specialty Clinics, Other End-Users.

Regional Dominance: North America Leads the Way

• North America emerges as the largest region in 2023.
• Reflective of evolving healthcare landscape.

Conclusion: Navigating the Coronary Artery Disease Market

• Growth trajectory remains steep with promising innovations.
• Collaboration and innovation key to addressing challenges.
• Market poised to witness transformative developments in the years ahead.

Request A Sample Of The Global Coronary Artery Disease Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=12052&type=smp